General Information:

Id: 1,572 (click here to show other Interactions for entry)
Diseases: Atherosclerosis
Diabetes mellitus, type II - [OMIM]
Insulin resistance
Homo sapiens
Reference: Mandosi E et al.(2010) Atorvastatin downregulates monocyte CD36 expression, nuclear NFkappaB and TNFalpha levels in type 2 diabetes J. Atheroscler. Thromb. 17: 539-545 [PMID: 20134099]

Interaction Information:

Comment Type 2 diabetic patients were treated for 8 weeks with atorvastatin, atorvastatin decreased total cholesterol and LDL cholesterol, and increased HDL cholesterol.
Formal Description
Interaction-ID: 11258

drug/chemical compound


increases_quantity of



in blood
Drugbank entries Show/Hide entries for Atorvastatin